Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Gamma-hydroxybutyrate detoxification by titration and tapering.

de Jong CA, Kamal R, Dijkstra BA, de Haan HA.

Eur Addict Res. 2012;18(1):40-5. doi: 10.1159/000333022. Epub 2011 Dec 3.

PMID:
22142784
2.

Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.

van Noorden MS, van Dongen LC, Zitman FG, Vergouwen TA.

Gen Hosp Psychiatry. 2009 Jul-Aug;31(4):394-6. doi: 10.1016/j.genhosppsych.2008.11.001. Epub 2008 Dec 25. Review.

PMID:
19555805
3.

[Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].

van Noorden MS, Kamal R, de Jong CA, Vergouwen AC, Zitman FG.

Ned Tijdschr Geneeskd. 2010;154:A1286. Review. Dutch.

PMID:
21040601
4.

[Detoxification of patients with GHB dependence].

de Weert-van Oene GH, Schellekens AF, Dijkstra BA, Kamal R, de Jong CA.

Tijdschr Psychiatr. 2013;55(11):885-90. Dutch.

5.

The gamma-hydroxybutyrate withdrawal syndrome.

Tarabar AF, Nelson LS.

Toxicol Rev. 2004;23(1):45-9. Review.

PMID:
15298492
6.

Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.

McDonough M, Kennedy N, Glasper A, Bearn J.

Drug Alcohol Depend. 2004 Jul 15;75(1):3-9. Review.

PMID:
15225884
7.

Gamma-hydroxybutyrate withdrawal syndrome.

Dyer JE, Roth B, Hyma BA.

Ann Emerg Med. 2001 Feb;37(2):147-53.

PMID:
11174231
8.

Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project.

Dijkstra BA, Kamal R, van Noorden MS, de Haan H, Loonen AJ, De Jong CA.

Drug Alcohol Depend. 2017 Jan 1;170:164-173. doi: 10.1016/j.drugalcdep.2016.11.014. Epub 2016 Nov 21.

PMID:
27923198
9.

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.

Galloway GP, Frederick SL, Staggers FE Jr, Gonzales M, Stalcup SA, Smith DE.

Addiction. 1997 Jan;92(1):89-96.

PMID:
9060200
10.

[Gamma-hydroxybutyrat (GHB)-dependence and -withdrawal in the case of previous alcohol dependence].

Richter C, Romanowski A, Kienast T.

Psychiatr Prax. 2009 Oct;36(7):345-7. doi: 10.1055/s-0028-1090089. Epub 2009 Jan 27. German.

PMID:
19173170
11.

Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.

Abanades S, Farré M, Segura M, Pichini S, Barral D, Pacifici R, Pellegrini M, Fonseca F, Langohr K, De La Torre R.

Ann N Y Acad Sci. 2006 Aug;1074:559-76.

PMID:
17105953
12.

The Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance: A Review.

Kamal RM, van Noorden MS, Franzek E, Dijkstra BA, Loonen AJ, De Jong CA.

Neuropsychobiology. 2016;73(2):65-80. doi: 10.1159/000443173. Epub 2016 Mar 23. Review.

13.

[GHB withdrawal delirium].

Stijnenbosch PJ, Zuketto C, Beijaert PJ, Maat A.

Ned Tijdschr Geneeskd. 2010;154:A1086. Dutch.

PMID:
20132572
14.

Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients.

Rosen MI, Pearsall HR, Woods SW, Kosten TR.

J Subst Abuse Treat. 1997 Mar-Apr;14(2):149-54.

PMID:
9258859
15.

Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report.

Glasper A, McDonough M, Bearn J.

Eur Addict Res. 2005;11(3):152-4.

PMID:
15990433
16.

[Life threatening symptoms of withdrawal of gamma-hydroxybutyrate].

Veerman SR, Dijkstra HN, Liefting-Kluft I.

Tijdschr Psychiatr. 2010;52(6):411-6. Dutch.

17.

Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity.

Brunt TM, Koeter MW, Hertoghs N, van Noorden MS, van den Brink W.

Drug Alcohol Depend. 2013 Aug 1;131(3):316-9. doi: 10.1016/j.drugalcdep.2012.12.023. Epub 2013 Jan 16.

PMID:
23332440
18.

Diazepam tapering in detoxification for high-dose benzodiazepine abuse.

Harrison M, Busto U, Naranjo CA, Kaplan HL, Sellers EM.

Clin Pharmacol Ther. 1984 Oct;36(4):527-33.

PMID:
6434221
19.

Gamma hydroxybutyrric acid (GHB) withdrawal does not occur at therapeutic dosage.

Addolorato G, Leggio L, Abenavoli L, Gasbarrini G, Caputo F, Vignoli T, Lorenzini F, Bernardi M.

Drug Alcohol Depend. 2005 Feb 14;77(2):209. No abstract available.

PMID:
15664723
20.

Gamma-hydroxybutyric acid tolerance and withdrawal in a rat model.

Bania TC, Ashar T, Press G, Carey PM.

Acad Emerg Med. 2003 Jul;10(7):697-704.

Supplemental Content

Support Center